Divyen
H. Patel Ph.D. Founder/CEO
Dr. Patel has focused his entire scientific career in trying to
find novel and innovative ways to improve the outcome in cancer
patients. He completed his Ph.D. at the University of Leeds in England,
publishing 14 publications as a graduate student, focusing on establishing
definitive methods for diagnosis of myeloid leukemia. He joined
the University of Tennessee in 1992 to study signal transduction
to get a better understanding of the causative agents of various
disease states. Dr. Patel started his work on differential gene
expression in 1994 when he joined St. Jude Children's Research Hospital
in Memphis TN. At the time he utilized the rudimentary tools available
to clone and characterize nucleoside transporter cDNAs. He subsequently
initiated and ran an Affymetrix GeneChip microarray facility at
St. Jude's. His extensive experience and background in the field
of gene expression research allowed him to help many investigators
to further their research projects.
Dr. R. Dale Childress M.D., CMO
Dr. Childress has maintained a life-long interest in research,
with his first co-authored publication in the American Journal
of Physiology at age 18. Dr.
Childress received his Masters of Science in Cellular and Molecular Biology in
1997 and his M.D. degree in 1999, both from Louisiana State University in Shreveport. He
obtained his Internal Medicine residency training and Endocrinology Fellowship
training at the University of Tennessee Health Science Center in Memphis. Dr.
Childress currently maintains a private endocrinology practice in the community
as well as working at the Memphis Veterans Affairs hospital where he serves as
an associate professor in the division of endocrinology. He serves on consultant
boards, as well as a speaker for several pharmaceutical companies. He also serves
as a peer reviewer for several scientific/clinical journals. In his current
capacity as CMO, Dr. Childress directly facilitates all clinical studies undertaken
by Genome Explorations. He provides an essential interface between scientific
advancements and clinical research.
Robert
J. Rooney Ph.D., Scientific Director
Prior to his move to Genome Explorations in July 2004, Dr. Rooney
was a faculty member in the Department of Molecular Genetics & Microbiology
at Duke University Medical Center from 1998 to 2004 and in the Department
of Biochemistry at St. Jude Children's Research Hospital from 1992 to 1998.
He received his Ph.D. from Columbia University and post-doctoral training
at The Rockefeller University and Duke University. Dr. Rooney has been the
principal investigator on multiple grants from the NIH and the American
Cancer Society and his research interests have encompassed mechanisms
regulating mammalian and viral gene transcription, cell cycle
control, signal transduction, apoptosis, and oncogenesis.
